Simplex Trading
BHVN

Simplex Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Simplex Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,100
Closed -$3.64M – 11193
2022
Q3 		$3.64M Buy
24,100
+14,300
+146% +$2.12M ﹤0.01% 1446
2022
Q2 		$1.43M Buy
9,800
+5,000
+104% +$639K ﹤0.01% 2221
2022
Q1 		$569K Sell
4,800
-1,300
-21% -$162K ﹤0.01% 3681
2021
Q4 		$840K Sell
6,100
-4,500
-42% -$572K ﹤0.01% 3095
2021
Q3 		$1.06M Hold
10,600
– – ﹤0.01% 2980
2021
Q2 		$1.03M Buy
10,600
+10,556
+23,991% +$857K ﹤0.01% 3075
2021
Q1 		$300K Sell
44
-158
-78% -$12.8K ﹤0.01% 4145
2020
Q4 		$1.73M Buy
202
+99
+96% +$8.39K ﹤0.01% 1923
2020
Q3 		$669K Sell
103
-234
-69% -$15.3K ﹤0.01% 2693
2020
Q2 		$2.46M Sell
337
-571
-63% -$30.4K ﹤0.01% 1351
2020
Q1 		$3.09M Buy
908
+604
+199% +$27.6K 0.01% 974
2019
Q4 		$1.65M Sell
304
-262
-46% -$13K ﹤0.01% 1643
2019
Q3 		$2.36M Buy
566
+400
+241% +$16.9K 0.01% 1206
2019
Q2 		$726K Buy
166
+125
+305% +$7.05K ﹤0.01% 2221
2019
Q1 		$211K Buy
41
+33
+413% +$1.43K ﹤0.01% 3557
2018
Q4 		$29K Buy
8
+7
+700% +$252 ﹤0.01% 5036
2018
Q3 		$3K Hold
1
– – ﹤0.01% 7043
2018
Q2 		$3K Sell
1
-213
-100% -$6.76K ﹤0.01% 7009
2018
Q1 		$4K Buy
+214
New +$6.4K ﹤0.01% 4929

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Simplex Trading's BHVN Position: Q3 2022 in Review

Simplex Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 4,426 shares — an estimated $656K sold.

Simplex Trading first reported a position in BHVN in Q4 2017 and held it in 13 quarters. The position peaked at $2.38M in Q2 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Simplex Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 4,426 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $656K.
  • Simplex Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 13 quarters.
  • Simplex Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.38M in Q2 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.